NCT00986882View on ClinicalTrials.gov

To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Postoperative Pain
Interventions
DRUG

SAF312A

DRUG

Placebo

DRUG

Ibuprofen

Trial Locations (1)

84124

Jean Brown Research, Salt Lake City

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00986882 - To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients | Biotech Hunter | Biotech Hunter